| 8778984 |
Aldosterone synthase inhibitor |
Paul J. Hoogestraat, Thomas E. Mabry, Quanrong Shen, Ana Maria Escribano |
2014-07-15 |
$65,923,000 |
| 8106077 |
Compounds and methods for modulating FXR |
Robert Anthony Doti, Matthew S. Dowling, Michael James Genin, Peter Ambrose Lander, Tianwei Ma +5 more |
2012-01-31 |
$97,135,000 |
| 7863302 |
Compounds and methods for modulating FX-receptors |
Michael James Genin, Peter Ambrose Lander, Lindsay Stelzer, Robert Anthony Doti, Francisco Javier Agejas-Chicharro +7 more |
2011-01-04 |
$52,639,000 |
| 7846960 |
FXR agonists |
Robert Anthony Doti, Michael James Genin, Peter Ambrose Lander, Tianwei Ma, Peter Rudolph Manninen +5 more |
2010-12-07 |
$56,095,000 |
| 7470705 |
Compounds and methods for treating dyslipidemia |
Guoqing CAO, Ana Maria Escribano, Maria Carmen Fernandez, Peter Ambrose Lander, Nathan B. Mantlo +4 more |
2008-12-30 |
$296,756,000 |
| 7411072 |
Tricyclic steroid hormone nuclear receptor modulators |
Michael J. Coghlan, Jonathan Edward Green, Timothy A. Grese, Prabhakar Kondaji Jadhav, Donald P. Matthews +2 more |
2008-08-12 |
$92,020,000 |
| 6579886 |
Selective iglur5 receptor antagonists |
Michael Edward Le Tourneau, Michael John Martinelli, Mark Alan Winter |
2003-06-17 |
$179,653,000 |
| 6265581 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews, John H. McDonald, III +4 more |
2001-07-24 |
$242,428,000 |
| 6133458 |
Benzo[B]indeno[2, 1-D]thiophene compounds, intermediates, compositions, and methods |
Brian S. Muehl, Mark Alan Winter |
2000-10-17 |
$162,752,000 |
| 6093735 |
Selective .beta.-3 adrenergic agonists |
Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews, John H. McDonald, III +4 more |
2000-07-25 |
$314,501,000 |
| 6075040 |
Selective .beta..sub.3 adrenergic agonists |
Thomas Alan Crowell, Cynthia Darshini Jesudason, Donald P. Matthews, John H. McDonald, III, David Andrew Neel +3 more |
2000-06-13 |
$150,326,000 |
| 6060492 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Donald P. Matthews, John H. McDonald, III, David Andrew Neel, Anthony John Shuker +1 more |
2000-05-09 |
$155,359,000 |
| 5977154 |
Selective .beta.3 adrenergic agonist |
Christine Ann Droste, Cynthia Darshini Jesudason, Christopher J. Rito, Anthony John Shuker, Mark Alan Winter |
1999-11-02 |
$60,888,000 |
| 5939443 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Christine Ann Droste, Donald P. Matthews, John H. McDonald, III, Christopher J. Rito +2 more |
1999-08-17 |
$154,268,000 |
| 5856341 |
Benzo B! indeno 2,1-D! thiophene compounds, intermediates, processes, compositions and methods |
Brian S. Muehl, Mark Alan Winter |
1999-01-05 |
$208,307,000 |
| 5840738 |
Selective .beta.-3 adrenergic agonists |
Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald P. Matthews, John H. McDonald, III +4 more |
1998-11-24 |
$147,364,000 |
| 5834488 |
Dihydrobenzo B! indeno 2, 1-D! thiophene compounds, intermediates, processes, compositions and methods |
Brian S. Muehl, Mark Alan Winter |
1998-11-10 |
$229,270,000 |
| 5808080 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, David Andrew Neel, Mark Alan Winter |
1998-09-15 |
$121,140,000 |
| 5786356 |
Selective .beta.3 adrenergic agonists |
Thomas Alan Crowell, Donald P. Matthews, John H. McDonald, III, David Andrew Neel, Anthony John Shuker +1 more |
1998-07-28 |
$113,899,000 |
